A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
CompletedNCT01946126
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.
Study details
- Conditions
- Interventions
- Sponsor
- Allergan
- Start date
- 2014-03
- Primary completion
- 2014-04
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months * Eight (8) headache days per month for at least 1 of the preceding 15 months Exclusion Criteria: * Not currently diagnosed with chronic migraine, headache or migraine * History of receiving botulinum toxin injections for the treatment of chronic migraine.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01946126